EFNB2 and neoplasm: Activation of ephrin-B2, through its PDZ domain, has also been shown to control VEGFR2 and VEGFR3 endocytosis and subsequent angiogenic sprouting, lymphangiogenic growth and tumor angiogenesis (Sawamiphak et al., 2010; Wang et al., 2010).